Viewing Study NCT05211232


Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2025-12-28 @ 10:47 PM
Study NCT ID: NCT05211232
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-18
First Post: 2022-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module